DXRXDiaceutics PLC
172.00GBp0.00%Mkt Cap: 145.56M GBpP/E: Last update: 2026-05-13

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for pr…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)
P/E (Forward)316.48
PEG
P/B3.84
P/S4.16
EV/EBITDA100.80
EV/Revenue3.89
EPS (TTM)-0.02
EPS (Forward)0.01
Cash Flow & Leverage
FCF Yield-2.82%
FCF Margin-11.92%
Operating CF651.00K GBp
CapEx (TTM)4.63M GBp
Net Debt/EBITDA-6.98
Net Debt-9.25M GBp
Technical
SMA 50159.87 (+7.6%)
SMA 200153.53 (+12.0%)
Beta0.92
S&P 52W Chg24.23%
Avg Vol (30d)174.81K
Avg Vol (10d)98.67K
Technical Indicators
RSI (14)58.7
MACD3.9881
MACD Signal4.3976
MACD Hist.-0.4094
BB Upper179.80 GBp
BB Middle170.43 GBp
BB Lower161.05 GBp
BB Width11.00%
ATR (14)5.054 GBp
Vol Ratio (20d)0.12x
52W Range
112.2588% of range180.00
52W High180.00 GBp
52W Low112.25 GBp
Profitability
Gross Margin87.91%
EBITDA Margin3.85%
Profit Margin-5.30%
Oper. Margin-21.83%
ROE-4.27%
ROA-3.50%
Revenue Growth18.20%
Earnings Growth
Balance Sheet
Debt/Equity0.03
Current Ratio3.96
Quick Ratio3.66
Book Value/Sh0.4400 GBp
Cash/Share0.1230 GBp
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 GBp
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Ownership
Shares Out.84.63M
Float48.61M
Insiders28.47%
Institutions61.79%
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)220.60 GBp
Target Range185.00 GBp243.00 GBp
# Analysts5
Company
Market Cap145.56M GBp
Enterprise Value133.66M GBp
Revenue (TTM)34.40M GBp
Gross Profit28.27M GBp
Net Income (TTM)-1.70M GBp
Revenue/Share0.4070 GBp
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees213
Last Price172.00 GBp
CountryGB
SectorHealthcare
IndustryHealth Information Services
ISIN